Show simple item record

Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma

dc.contributor.authorFang, Jianming M.en_US
dc.contributor.authorArlt, Martin F.en_US
dc.contributor.authorBurgess, Ann C.en_US
dc.contributor.authorDagenais, Susan L.en_US
dc.contributor.authorBeer, David G.en_US
dc.contributor.authorGlover, Thomas W.en_US
dc.date.accessioned2006-04-19T14:11:36Z
dc.date.available2006-04-19T14:11:36Z
dc.date.issued2001-03en_US
dc.identifier.citationFang, Jianming M.; Arlt, Martin F.; Burgess, Ann C.; Dagenais, Susan L.; Beer, David G.; Glover, Thomas W. (2001)."Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma." Genes, Chromosomes and Cancer 30(3): 292-298. <http://hdl.handle.net/2027.42/35130>en_US
dc.identifier.issn1045-2257en_US
dc.identifier.issn1098-2264en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/35130
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11170287&dopt=citationen_US
dc.description.abstractCommon fragile sites have been proposed to play a mechanistic role in chromosome translocations and other rearrangements in cancer cells in vivo based on their behavior in vitro and their co-localization with cancer translocation breakpoints. This hypothesis has been the subject of controversy, because associations have been made at the chromosomal level and because of the large number of both fragile sites and cancer chromosome breakpoints. Tests of this hypothesis at the molecular level are now possible with the cloning of common fragile site loci and the use of fragile site clones in the analysis of rearranged chromosomes. FRA3B, the most frequently seen common fragile site, lies within the large FHIT gene. It is now well established that this region is the site of frequent, large intragenic deletions and aberrant transcripts in a number of tumors and tumor cell lines. In contrast, only one tumor-associated translocation involving the FHIT gene has been reported. We have found translocations in both homologs of chromosome 3 in an early-passage esophageal adenocarcinoma cell line. This cell line showed no normal FHIT transcripts by reverse transcription polymerase chain reaction. Subsequent chromosome analysis showed translocations of the short arms of both homologs of chromosome 3: t(3;16) and t(3;4). The breakpoints of both translocations were shown by fluorescence in situ hybridization and polymerase chain reaction to be in the FHIT gene, at or near the center of the fragile site region. Using rapid amplification of cDNA ends with FHIT primers, a noncoding chimeric transcript resulting from t(3;16) was identified. These data provide direct support for the hypothesis that FRA3B , and likely other common fragile sites, may be “hot spots” for translocations in certain cancers, as they are for deletions, and that such translocations have the potential to form abnormal chimeric transcripts. In addition, the results suggest selection for loss of a functional FHIT gene by the translocation events. © 2001 Wiley-Liss, Inc.en_US
dc.format.extent221745 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherJohn Wiley & Sons, Inc.en_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherCancer Research, Oncology and Pathologyen_US
dc.titleTranslocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinomaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeneticsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan ; Department of Human Genetics, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan ; Department of Human Genetics, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Pediatrics, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan ; Department of Human Genetics, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Surgery, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Pediatrics, University of Michigan, Ann Arbor, Michigan ; Department of Human Genetics, University of Michigan, Ann Arbor, Michigan ; Department of Human Genetics, Box 0618, 4909 Buhl, University of Michigan, Ann Arbor, MI 48109–0618en_US
dc.identifier.pmid11170287en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/35130/1/1095_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/1098-2264(2000)9999:9999<::AID-GCC1095>3.0.CO;2-Fen_US
dc.identifier.sourceGenes, Chromosomes and Canceren_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.